| Followers | 202 |
| Posts | 25627 |
| Boards Moderated | 0 |
| Alias Born | 04/03/2010 |
Sunday, August 13, 2023 2:55:42 PM
No, it is not. It is a UK property belonging to a UK located landlord. It will have no bearing.
The lease predates the newer regulations like the Entity List designation and the CHIPS Act provisions. It is typically therefore grandfathered in under previous rules.
The lease is for physical property located in the UK. The US rules are focused on export controls and domestic investments, so they do not directly apply to a foreign real estate transaction.
Huawei's role as landlord is circumstantial and passive. This is not an active business collaboration that raises data or technology sharing concerns.
A basic real estate lease is fairly routine business activity. It does not imply a deeper partnership or investment with Huawei.
NWBO is not providing Huawei any technology, equipment or other exports that could be regulated by US trade controls.
NWBO is not investing in Huawei or forming a joint venture arrangement that could raise financial oversight issues.
However, the NWBO team itself and their counsel are likely very much aware of those issues and it’s doubtful they have not previously considered all of the issues. I would not claim legal expertise, but I expect that the NWBO team has all the legal advice they need and ever needed to ensure they insulated themselves. In fact they went into great detail about the security on the grounds and other protections related to Huawei being their landlord in one of their annual meetings, as I recall.
I am glad I was so loud on those issues when all of this first came up.
The lease predates the newer regulations like the Entity List designation and the CHIPS Act provisions. It is typically therefore grandfathered in under previous rules.
The lease is for physical property located in the UK. The US rules are focused on export controls and domestic investments, so they do not directly apply to a foreign real estate transaction.
Huawei's role as landlord is circumstantial and passive. This is not an active business collaboration that raises data or technology sharing concerns.
A basic real estate lease is fairly routine business activity. It does not imply a deeper partnership or investment with Huawei.
NWBO is not providing Huawei any technology, equipment or other exports that could be regulated by US trade controls.
NWBO is not investing in Huawei or forming a joint venture arrangement that could raise financial oversight issues.
However, the NWBO team itself and their counsel are likely very much aware of those issues and it’s doubtful they have not previously considered all of the issues. I would not claim legal expertise, but I expect that the NWBO team has all the legal advice they need and ever needed to ensure they insulated themselves. In fact they went into great detail about the security on the grounds and other protections related to Huawei being their landlord in one of their annual meetings, as I recall.
I am glad I was so loud on those issues when all of this first came up.
Bullish
I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
